Nicox S.A. (ALCOX.PA)

EUR 0.22

(-4.48%)

Net Income Summary of Nicox S.A.

Nicox S.A.'s latest annual net income in 2023 was -20.88 Million EUR , up 33.26% from previous year.
Nicox S.A.'s latest quarterly net income in 2023 FY was -20.88 Million EUR , up 33.26% from previous quarter.
Nicox S.A. reported an annual net income of -31.28 Million EUR in 2022, up 28.51% from previous year.
Nicox S.A. reported an annual net income of -43.76 Million EUR in 2021, down -141.8% from previous year.
Nicox S.A. reported a quarterly net income of -20.88 Million EUR for 2023 FY, up 33.26% from previous quarter.
Nicox S.A. reported a quarterly net income of -3303.00 EUR for 2023 Q2, down 0.0% from previous quarter.

Annual Net Income Chart of Nicox S.A. (2023 - 2019)

Historical Annual Net Income of Nicox S.A. (2023 - 2019)

Year	Net Income	Net Income Growth
2023	-20.88 Million EUR	33.26%
2022	-31.28 Million EUR	28.51%
2021	-43.76 Million EUR	-141.8%
2020	-18.09 Million EUR	0.0%
2019	- EUR	0.0%

Year	Net Income	Net Income Growth
2023 Q1	-3303.00 EUR	38.57%
2023 FY	-20.88 Million EUR	33.26%
2023 Q2	-3303.00 EUR	0.0%
2022 FY	-31.28 Million EUR	28.51%
2022 Q4	-5376.50 EUR	0.0%
2021 FY	-43.76 Million EUR	-141.8%
2020 FY	-18.09 Million EUR	0.0%
2019 FY	- EUR	0.0%

Peer Net Income Comparison of Nicox S.A.

Name	Net Income	Net Income Difference
European Medical Solutions	-709 Thousand EUR	-2845.134%
FERMENTALG	-14.14 Million EUR	-47.59%
argenx SE	-272.91 Million EUR	92.349%
BioSenic S.A.	-28.77 Million EUR	27.441%
Celyad Oncology SA	-8.44 Million EUR	-147.171%
Hyloris Pharmaceuticals SA	-15.38 Million EUR	-35.767%
Onward Medical N.V.	-36.18 Million EUR	42.287%
Oxurion NV	-18.96 Million EUR	-10.08%
PHAXIAM Therapeutics S.A.	-23.48 Million EUR	11.099%
Financière de Tubize SA	88.15 Million EUR	123.688%
UCB SA	343 Million EUR	106.088%